See also this year's filing and all EDGAR filings for this company.
PDF Report 0001636282_2026_Spyre_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001636282, Spyre Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 777,781,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 58,685,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 3,860,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 50,406,870 |
| 9 | ResearchAndDevelopmentExpense | 178,468,553 |
| 10 | remainder_Expenses | -6,794,725 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 44,360,919 |
| 13 | remainder_ComprehensiveNetIncome | -121,299 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 777,781,000 |
| 1 | Liabilities | 62,545,000 |
| 2 | Expenses | 222,080,698 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 715,236,000 |
| 5 | NetIncome | -177,719,779 |
| 6 | ComprehensiveNetIncome | -177,780,428 |
| 7 | BaseVar | 553,444,458 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.29 |
| 9 | EconomicCapitalRatio | 3.88 |
Edgar->Model Mapping
Feature Distribution
Change over Time
